secwatch.observer — SEC 8-K summary
======================================

Issuer:     Regen BioPharma Inc (RGBP)
CIK:        0001589150
Form:       8-K
Filed at:   2022-01-14T23:59:59+00:00
Accession:  0001607062-22-000013
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Regen Biopharma subleases office space from BST Partners controlled by CEO David Koos at $5,000/month
--------------------------------------------------------------------------------

- Entered into month-to-month sublease with BST Partners for office space at 4700 Spring Street, Suite 304, La Mesa, CA starting January 14, 2022.
- Monthly rent of $5,000 payable to BST Partners, which is controlled by David Koos, Regen's sole officer and director.
- Sublease creates a direct financial obligation and is a related-party transaction due to Koos's control of both entities.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1589150/000160706222000013/0001607062-22-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1589150/000160706222000013/rgbp011322form8k.htm
  HTML page:      https://secwatch.observer/filing/0001607062-22-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer